Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇵🇹PT · Medicine#185500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
250 to 1.5K🎙 ~2x weekly·379 episodes·Last published 3d ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇵🇹100% - Active Followers
Loyal subscribers who consistently listen
200 to 1.2K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHost
Recent guests
Recent episodes
Personalized Therapy Growth Driven by Clinical Diagnostics
Jun 25, 2026
16m 03s
How Pharmacogenomics Deliver More Precise Cancer Therapy
Jun 11, 2026
20m 52s
Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread
May 28, 2026
23m 08s
Lab Stewardship in Modern Healthcare
May 14, 2026
15m 53s
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Apr 23, 2026
17m 17s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/25/26 |  Personalized Therapy Growth Driven by Clinical Diagnostics | In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how clinical diagnostics are powering more personalized care. Together, they explore: Point-of-care testing in outbreak response (00:29): Hear about the potential and limitations of point-of-care testing during disease outbreaks.A rare type of Lyme disease (02:46): Learn about the spread of the second known pathogen to cause Lyme disease in the U.S.The evolution of AI (04:50): Dr. Morice shares insights from a recent conference, highlighting the shift from discussing artificial intelligence’s potential to scaling real-world clinical applications.Personalized medicine and diagnostics (06:07): Discover how clinical diagnostics are driving personalized medicine and how data will shape its future.ResourcesFour ways diagnostics are driving more personalized care"Answers From the Lab" podcast: Advancing Precision Medicine Through Therapeutic Tests"Answers From the Lab" podcast: Risks Increase as Ticks, Mosquitoes, and Similar Vectors SpreadTherapeutics testing: Discover the differences | 16m 03s | ||||||
| 6/11/26 |  How Pharmacogenomics Deliver More Precise Cancer Therapy✨ | pharmacogenomicscancer therapy+4 | William Morice II, M.D., Ph.D.Ann Moyer, M.D., Ph.D. | Mayo ClinicMayo Clinic Laboratories+5 | — | pharmacogenomicscancer treatment+5 | — | 20m 52s | |
| 5/28/26 |  Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread✨ | vector-borne diseasesinfectious diseases+4 | William Morice II, M.D., Ph.D.Elli Theel, Ph.D. | Mayo ClinicMayo Clinic Laboratories+1 | — | ticksmosquitoes+6 | — | 23m 08s | |
| 5/14/26 |  Lab Stewardship in Modern Healthcare✨ | laboratory stewardshiphealthcare strategies+3 | Brad Karon, M.D., Ph.D. | Mayo ClinicMayo Clinic Laboratories+1 | — | lab stewardshiphealthcare systems+3 | — | 15m 53s | |
| 4/23/26 |  Unique Assays Advance Care of Complex Autoimmune Skin Conditions✨ | laboratory medicineautoimmune diseases+4 | William Morice II, M.D., Ph.D.Julia Lehman, M.D. | Mayo ClinicMayo Clinic Laboratories | — | autoimmune skin conditionslaboratory medicine+4 | — | 17m 17s | |
| 4/9/26 |  Digital Advances: What’s Next for Clinical Diagnostics?✨ | clinical diagnosticsdigital innovation+3 | William Morice II, M.D., Ph.D.Chris Garcia, M.D. | Mayo Clinic LaboratoriesMayo Clinic | — | clinical diagnosticsdigital innovation+3 | — | 26m 05s | |
| 3/19/26 |  Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes✨ | preeclampsiatest development+4 | William Morice II, M.D., Ph.D.Janelle Santos, M.D. | Mayo ClinicMayo Clinic Laboratories | — | preeclampsia testMayo Clinic+5 | — | 17m 33s | |
| 3/5/26 |  Breakthrough Test Enhances Peripheral Neuropathy Care and Research✨ | diagnostic innovationspatient care+4 | William Morice II, M.D., Ph.D.Matthew Schultz, Ph.D. | Mayo ClinicMayo Clinic Laboratories | — | peripheral neuropathydiagnostic innovations+4 | — | 16m 59s | |
| 2/19/26 |  How Strategic Collaborations Transform Clinical Diagnostics✨ | clinical diagnosticscollaboration+3 | William Morice II, M.D., Ph.D. | Mayo Clinic LaboratoriesFDA | — | clinical diagnosticscollaboration+3 | — | 15m 06s | |
| 2/5/26 |  Innovation and Resilience in Lab Logistics✨ | lab logisticsPAMA reform+3 | William Morice II, M.D., Ph.D.Angie Reese-Davis | Mayo Clinic LaboratoriesMayo Clinic+2 | — | lab logisticsPAMA reform+5 | — | 15m 12s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/22/26 |  2026 Forecast: Trends Shaping the Future of Diagnostics✨ | future of diagnosticsartificial intelligence+3 | William Morice II, M.D., Ph.D. | Mayo Clinic LaboratoriesMayo Clinic | — | diagnosticsartificial intelligence+5 | — | 16m 19s | |
| 1/8/26 |  Speed Without Sacrifice: How Diagnostics Can Move Quickly and Safely✨ | direct-to-consumer testinginnovation in diagnostics+3 | William Morice II, M.D., Ph.D.Matthew Binnicker, Ph.D. | Mayo Clinic Laboratories | — | diagnosticsdirect-to-consumer testing+6 | — | 16m 04s | |
| 12/18/25 |  Breakthroughs and Trends That Defined Lab Medicine in 2025✨ | lab medicinehealth during holidays+4 | William Morice II, M.D., Ph.D. | Mayo Clinic LaboratoriesMayo Clinic | — | lab medicineinfluenza+5 | — | 12m 55s | |
| 12/4/25 |  Accelerating Research and Development With BioPharma Diagnostics✨ | PAMA reformalpha-gal syndrome+3 | William Morice II, M.D., Ph.D.Chris Garcia, M.D. | biopharma diagnosticsMayo Clinic Laboratories | — | PAMA reformalpha-gal syndrome+5 | — | 24m 25s | |
| 11/20/25 |  Unlocking the Unknown With Metagenomics | In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent news about Protecting Access to Medicare Act (PAMA) reform. Then, Dr. Pritt welcomes Trish Simner, Ph.D., a clinical microbiologist at Mayo Clinic, for an in-depth conversation about metagenomics. PAMA reform update and new RESULTS Act (00:30): Hear about options under consideration for PAMA reform, including the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.When cerebrospinal fluid (CSF) metagenomics benefit patient care (06:04): Explore how CSF metagenomics work and when it is appropriate to use this advanced diagnostic tool in clinical practice.Advancement and innovation in metagenomics (18:15): Discover how recent and upcoming innovation is expanding metagenomic testing capabilities. Note: Information in this post was accurate at the time of its posting.ResourcesAnswers From the Lab podcast: Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.Metagenomics: Identifying elusive pathogenic microorganisms | 26m 27s | ||||||
| 11/6/25 |  Forging Collaborations That Deliver Better Outcomes | In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories. Together, they discuss recent news about virus activity and explore the value of collaboration in shaping innovative diagnostic strategies. Testing for viruses appearing closer to home (00:45): Gain insights on using available testing to manage measles and detect chikungunya, which was recently transmitted in the U.S. for the first time in years. Collaborating for more coordinated care and innovation (06:04): Explore how strategic partnerships in diagnostics foster innovation and enable a more integrated approach to clinical decision-making.Building successful collaborations (12:16): Discover practical insights into establishing and maintaining collaborations that deliver meaningful value to all involved. Note: Information in this post was accurate at the time of its posting.ResourcesAnswers From the Lab Podcast: How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D. Dr. Bill Morice shares how a platform for collaboration transforms diagnosticsMary Jo Williamson offers four steps to maximize collaboration benefits | 17m 12s | ||||||
| 10/23/25 |  Advancing Precision Medicine Through Therapeutic Tests | In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent news about drug-resistant infections. Later, Paul Jannetto, Ph.D., director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab, joins Dr. Pritt for the deep dive segment. Together, they explore how diagnostics are shaping the future of therapeutics. New podcast format launch (00:25): Drs. Morice and Pritt introduce the exciting new format for “Answers From the Lab,” including the addition of in-depth expert segments. Drug-resistant infections (02:05): Discover how clinical diagnostics play a critical role in combating the growing threat of antibiotic resistance. Diagnostics’ role in advancing precision medicine (13:28): Learn how diagnostics, specifically drug monitoring, are advancing personalized therapies and contributing to better outcomes. Note: Information in this post was accurate at the time of its posting. Resources Therapeutics testing: A clear path to accurate answers Therapeutics testing at Mayo Clinic Laboratories WHO warns of widespread resistance to common antibiotics worldwide Tests for infectious disease detection and identification Connect with Us Is there a question or topic you’d like us to explore in a future episode? Email us at mayocliniclabs@mayo.edu. Learn more about our hosts and guests and connect with them on social media. Bobbi Pritt, M.D. Bio | LinkedIn Bill Morice, M.D., Ph.D. Bio | LinkedIn Paul Jannetto, Ph.D. Bio | LinkedIn | 30m 10s | ||||||
| 10/16/25 | Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D. | Published October 16, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent regulatory and policy developments. Together, they explore:FDA rescinds rule on LDTs (00:48): The FDA has officially withdrawn its rule that would allow oversight of laboratory-developed tests (LDTs) as medical devices. The conversation explores what this decision means and what might come next for LDT regulation.PAMA reform update and new RESULTS Act (05:13): The newly introduced Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act aims to address reimbursement for laboratory tests.Getting engaged (12:37): Why it is important to understand new regulatory policies and help others understand their implications for the industry.ResourcesFind past “Answers From the Lab” podcasts on LDTs and PAMA | 15m 52s | ||||||
| 10/2/25 | Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D. | Published October 2, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, discuss the latest developments in self-collection testing for women’s health and beyond. Together, they explore:New podcast format launching (00:01): Dr. Pritt previews exciting changes coming to “Answers From the Lab.” Emerging self-collection tests (01:21): Explore the growing range of self-collection tests now available for use in both clinical settings and at home.Validation of self-collection tests (03:19): Learn how laboratorians validated recent self- and home-collection tests to ensure quality and accuracy. Benefits for patients and public health (06:56): Understand the benefits self-collection tests offer to patients and how the tests impact public health.Limitations and implementation considerations (08:23): Review key factors to consider when incorporating self-collection testing into clinical care.Future innovation (11:34): Insights into where self-collection testing may evolve in the years ahead. | 14m 16s | ||||||
| 9/11/25 | Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D. | Published September 11, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss troublesome organisms making headlines. Together, they explore:Vibrio vulnificus (01:09): How people get this “flesh-eating” bacteria, how it affects patients, and a recent case that brought it into the spotlight.Staying safe (03:44): Discover when to seek medical attention and how knowledge can protect you as Vibrio vulnificus bacterium becomes more prevalent. New World screwworm (06:50): How this parasitic infection damages human tissue, how it was previously eradicated, and why it's making the news again. ABCs of protection (12:16): A simple reminder to avoid exposure, use bug spray, and wear protective clothing to shield against hazardous organisms.Laboratory as first line of defense (13:34): Laboratorians have a critical role in identification and monitoring broader trends when these types of cases arise. ResourcesA-Zs for prevention and exposure risks | 15m 44s | ||||||
| 9/2/25 |  Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC | Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC, explain how Mayo Clinic Laboratories' WESPR whole exome sequencing reflex test provides cost-effective diagnosis of complex genetic conditions. Using samples and data from previous targeted gene panels, WESPR's wider net can identify undetected genetic variants.(00:32) Would each of you share a little bit about yourselves and your background? (01:42)Could you provide us with an overview of the whole exome reflexing panel? (02:53) Is this different from our whole exome sequencing panel and our whole exome reanalysis panel? (04:00) Tell us more about who benefits from this test. (06:17) What is the clinical utility of this testing? (08:07)Would you help providers understand how to go about ordering? (11:23)Could you tell us more about the types of variants identified by this test? (13:39)Based on those performance characteristics, how does our test match up to other exome tests available in the market? (14:30)Are there any other unique features you would like to highlight? (15:57)What is the turnaround time for the reflex panel? (16:14)Can the results from the WESPR test be reanalyzed in the future as new genetic knowledge emerges? (16:56)How are variants reported, especially variants of uncertain significance? And does the report include recommendations? (19:31)Would you summarize the benefits of the WESPR at Mayo Clinic Laboratories? | 22m 13s | ||||||
| 8/28/25 | Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D. | Published August 28, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Matthew Binnicker, Ph.D., a microbiologist and virologist and chief scientific officer of Mayo Clinic Laboratories, discuss recent developments in viral infections. Together, they explore:Shope papilloma virus in rabbits (01:05): Unusual growths raise concern, though the virus poses minimal risk to humans and has actually benefitted research for other papilloma viruses. Chikungunya virus (07:07): What it is, how it spreads, who is at risk, and best practices for testing. Back-to-school viral trends (12:19): Common viruses that circulate during the school season, tips for keeping kids safe, and guidance for physicians on when to test. The laboratorian’s role (18:27): How laboratory professionals contribute to managing viral infections within hospital systems and the broader community.ResourcesForbes article: Is the ‘zombie rabbits’ virus a threat to humans?Mosquito-borne disease testing overviewMosquito-borne testing algorithms and interpretationsSearch our test catalog for more on testing for viral infections | 21m 21s | ||||||
| 8/14/25 | The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D. | Published August 14, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare. Together, they explore:Applications of AI tools in clinical diagnostics to identify dementia, cardiovascular conditions, and parasites.Ethical considerations, including global disparities in access to AI tools and environmental impacts.ResourcesUse of artificial intelligence and digital slide scanning for detection of intestinal protozoa in trichrome-stained stool specimensMayo Clinic's AI tool identifies 9 dementia types, including Alzheimer's, with one scanAI computing power is splitting the world into haves and have-nots - The New York Times | 11m 20s | ||||||
| 7/31/25 | New Tools for the Changing Landscape of Tick-Borne Diseases: Elitza Theel, Ph.D. | In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a timely discussion on tick-borne diseases. Topics covered include:Observations from this year’s tick season as we approach the end of July — a peak month for tick-borne disease transmission — along with trends in reported tick-borne pathogens over the past two decades.Algorithms developed by Mayo Clinic to guide clinicians in selecting the right tests for tick-borne and mosquito-borne diseases. The emergence of rare and esoteric infections and the challenges posed by vectors that carry and transmit multiple pathogens in a single bite.Shotgun metagenomics’ growing role in the diagnosis of vector-borne infections.More resources Read "Update on North American tick-borne diseases and how to diagnose them" in the Journal of Clinical Microbiology for more insights from Drs. Pritt and Theel. You can also explore tools and information from Mayo Clinic Laboratories, including region-specific details, algorithms, prevention tools, and more. | 15m 33s | ||||||
| 7/17/25 | How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D. | In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss summertime illnesses and key insights from a recent diagnostic investment event. Together, they explore:Common summertime illnesses, along with tips for prevention. How investment in diagnostic tools influences innovation in the laboratory.The potential impact of growing interest in AI investments. The investment interest in liquid biopsy and its potential implications for clinical decision-making.How AI development may accelerate adoption of mass spectrometry, proteomics, and similar advancements in clinical laboratories. | 12m 32s | ||||||
Showing 25 of 384
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.